(Q26823902)

English

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

scientific article

In more languages

Statements

scholarly article

1 reference

8 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

28 September 2019

2 October 2019

27 November 2019

3 May 2021

1 reference

based on heuristic

inferred from title

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (English)

1 reference

0 references

7 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

28 September 2019

2 October 2019

27 November 2019

cerebrovascular disease

3 references

22 March 2019

25 April 2019

17 June 2019

1 reference

28 September 2019

mechanism of action

1 reference

2 October 2019

1 reference

27 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

tissue plasminogen activator

1 reference

3 May 2021

Jonathan Emberson

object named as

Jonathan Emberson

1

0 references

William Whiteley

object named as

William Whiteley

26

0 references

object named as

Joanna Wardlaw

25

0 references

Richard I Lindley

object named as

Richard I Lindley

17

0 references

Geoffrey A. Donnan

object named as

Geoffrey Donnan

10

0 references

George A. Howard

object named as

George Howard

12

0 references

object named as

Markku Kaste

13

0 references

Maarten G. Lansberg

object named as

Maarten Lansberg

16

0 references

7

object named as

Thomas Brott

1 reference

Gregory J del Zoppo

27

object named as

Gregory J del Zoppo

1 reference

22

object named as

Danilo Toni

1 reference

Peter Sandercock

29

object named as

Peter Sandercock

1 reference

author name string

Kennedy R Lees

2

1 reference

Patrick Lyden

3

1 reference

Lisa Blackwell

4

1 reference

Gregory Albers

5

1 reference

Erich Bluhmki

6

1 reference

Geoff Cohen

8

1 reference

Stephen Davis

9

1 reference

James Grotta

11

1 reference

Masatoshi Koga

14

1 reference

Ruediger von Kummer

15

1 reference

Gordon Murray

18

1 reference

Jean Marc Olivot

19

1 reference

Mark Parsons

20

1 reference

Barbara Tilley

21

1 reference

Kazunori Toyoda

23

1 reference

Nils Wahlgren

24

1 reference

Colin Baigent

28

1 reference

Werner Hacke

30

1 reference

language of work or name

1 reference

publication date

29 November 2014

9 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

28 September 2019

2 October 2019

27 November 2019

3 May 2021

9 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

28 September 2019

2 October 2019

27 November 2019

3 May 2021

384

1 reference

9958

1 reference

1929-35

1 reference

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

7 April 2017

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

7 April 2017

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

7 April 2017

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

7 April 2017

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

7 April 2017

The effect of time to treatment on outcome in very elderly thrombolysed stroke patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Population shifts and the future of stroke: forecasts of the future burden of stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 September 2017

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

31 May 2018

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

31 May 2018

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

19 June 2018

Intravenous alteplase for stroke in those older than 80 years old.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 November 2018

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 November 2018

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 November 2018

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441266

28 November 2018

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960584-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960584-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960584-5

7 January 2021

based on heuristic

inferred from DOI database lookup

[Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25106063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26823902&oldid=2120251220"